(NASDAQ: MGRM) Monogram Orthopaedics's forecast annual revenue growth rate of 466.82% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.11%.
Monogram Orthopaedics's revenue in 2024 is $364,999.On average, 1 Wall Street analysts forecast MGRM's revenue for 2024 to be $35,113,734, with the lowest MGRM revenue forecast at $35,113,734, and the highest MGRM revenue forecast at $35,113,734. On average, 1 Wall Street analysts forecast MGRM's revenue for 2025 to be $179,048,412, with the lowest MGRM revenue forecast at $179,048,412, and the highest MGRM revenue forecast at $179,048,412.
In 2026, MGRM is forecast to generate $898,721,798 in revenue, with the lowest revenue forecast at $898,721,798 and the highest revenue forecast at $898,721,798.